CompletedPhase 3NCT03439124

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Studying Cap myopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Basilea Pharmaceutica
Principal Investigator
Marc Engelhardt, MD
Basilea Pharmaceutica
Intervention
ceftobiprole medocaril(drug)
Enrollment
138 target
Eligibility
17 years · All sexes
Timeline
20172020

Study locations (19)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03439124 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy

← Back to all trials